Theratechnologies Inc.

NASDAQ: THTX · Real-Time Price · USD
3.25
0.03 (0.93%)
At close: Aug 15, 2025, 12:19 PM

Theratechnologies Balance Sheet Statement

Financials in USD. Fiscal year is December - November.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Nov 30, 2024 Nov 30, 2023 Nov 30, 2022 Nov 30, 2021
Cash & Equivalents
5.9M 34.1M 23.86M 20.4M
Short-Term Investments
3.72M 6.29M 9.21M 19.95M
Long-Term Investments
214K n/a n/a n/a
Other Long-Term Assets
271K n/a 1.79M 621K
Receivables
14.97M 12.8M 10.66M 9.26M
Inventory
5.28M 6.07M 19.69M 29.14M
Other Current Assets
10.65M 892K 2.29M 2.41M
Total Current Assets
43.98M 63.3M 73.37M 91.91M
Property-Plant & Equipment
1.26M 1.98M 3.09M 2.85M
Goodwill & Intangibles
7.57M 12.5M 15.01M 23.83M
Total Long-Term Assets
9.36M 14.47M 19.89M 27.3M
Total Assets
53.34M 77.77M 93.26M 119.21M
Account Payables
6.33M 6.99M 12.89M 15.53M
Deferred Revenue
38K 38K 38K 54K
Short-Term Debt
3.49M 7.29M 64.79M n/a
Other Current Liabilities
8.78M 12.57M 10.79M 4.24M
Total Current Liabilities
36.86M 47.29M 114.28M 45.08M
Long-Term Debt
40.94M 50.69M n/a 54.23M
Other Long-Term Liabilities
21K 84K 106K 94K
Total Long-Term Liabilities
41.75M 51.34M 1.55M 56.38M
Total Liabilities
78.61M 98.64M 115.83M 101.45M
Total Debt
45.61M 58.97M 66.71M 56.74M
Common Stock
363.93M 363.93M 338.75M 335.75M
Retained Earnings
-416.89M -408.66M -382.65M -335.25M
Comprehensive Income
898K 684K 385K -44K
Shareholders Equity
-25.27M -20.87M -22.57M 17.76M
Total Investments
3.94M 6.29M 9.21M 19.95M